Login to Your Account



Roche, Genentech Finally Agree to Acquisition at $95 per Share

By Jennifer Boggs


Friday, March 13, 2009
The acquisition everyone has expected since Roche Holdings AG first made an offer eight months ago finally looks to happen, as Genentech Inc. agreed to a takeover by its Swiss pharma partner in a deal valued at about $46.8 billion. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription